top of page
  • Writer's pictureAventria Health Group

Is Your Brand Content Where Your Patients Are?

Pharmaceutical vice presidents, executive directors, brand leads, marketing leads, and commercial leads:

Many brands are challenged to transform their approach for reaching targeted patients with data-driven, segment-specific messages. While direct-to-consumer (DTC) advertising has its place, brand plans missing a direct-to-patient (DTP) component are definitely driving suboptimal results.

What’s the difference?

  • DTC advertising is a broad-reaching campaign designed to reach anyone who may have a certain condition and, therefore, a candidate for a treatment.

  • DTP advertising is a hyper-targeted campaign that reaches patients who have a certain condition and/or are taking medication for that condition. It can also target patients who have been in a prescriber’s practice.

To improve brand performance and patient outcomes, manufacturers need to reimagine routine nonpersonal promotion strategies. One proven adjustment is to add a platform that delivers relevant messaging to hyper-targeted patients.

Our Solution: RAMP-UP™ DTP

Our Rapid Access Messaging Platform, RAMP-UP DTP, delivers hyper-targeted ads online in places proven to be frequented by your targeted patients. The ads feature messaging to guide patients to your brand’s Web site, patient hub, etc.

RAMP-UP DTP can help you:

  • Identify the most valuable patients

  • Activate multichannel campaigns to reach them in real time

  • Amplify your sales efforts with instant learnings from real-time metrics

Client audits have proven RAMP-UP DTP increases prescriptions.* One client DTP audit of RAMP-UP DTP demonstrated: • An 8% increase in brand prescriptions of those exposed • A 3% decrease in brand prescriptions of those not exposed

The benefits of this program are high response and high value, as marketers are not overbuying or overreaching. This balanced combination of the right messages to the right audiences can deliver both quick and sustained impact.

To learn more about RAMP-UP, please reach out to:

Dave Dierk, Co-President, 30-year sales and marketing thought leader in pharmaceutical diagnostics, biomedical, long-term care, managed care, employer, and pharmacy communications, at

Heather Collins, VP, Account Services and Innovations, 17+ years of experience in new and emerging technologies within healthcare and managed markets, including EHR solutions, mobile applications, user experience, content management systems, search engine optimization, and brand identity, at

Making a difference in patient care by helping patients, providers, and payers collaborate on shared priorities

*Past performance of the RAMP-UP program is not a predictor of future performance or a guarantee of increased prescriptions.


bottom of page